{"id":1036318,"date":"2012-04-26T08:11:12","date_gmt":"2012-04-26T08:11:12","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/senator-hagan-honored-as-bio-legislator-of-the-year.php"},"modified":"2024-08-17T15:55:30","modified_gmt":"2024-08-17T19:55:30","slug":"senator-hagan-honored-as-bio-legislator-of-the-year","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/senator-hagan-honored-as-bio-legislator-of-the-year.php","title":{"rendered":"Senator Hagan Honored as BIO Legislator of the Year"},"content":{"rendered":"<p><p>      WASHINGTON--(BUSINESS WIRE)--    <\/p>\n<p>      The Biotechnology Industry Organization (BIO) announced today      its selection of Senator Kay Hagan (D-NC) as Legislator of      the Year for 2011-2012. Senator Hagan receives the award in      conjunction with todays BIO Legislative Day Fly-In      reception.    <\/p>\n<p>      As the sponsor of the       TREAT Act, Senator Hagan has offered renewed hope to      patients desperately in need of cures and breakthrough new      medicines as well as a boost to our nations economy. The      legislation will help the U.S. Food and Drug Administration      (FDA) retain its leadership position as the global gold      standard for regulatory science and consumer protection,      said BIO President and CEO Jim Greenwood.    <\/p>\n<p>      Senator Hagan has distinguished herself as a strong leader      for national policy that will help our nations biotechnology      sector thrive and benefit people everywhere.She is a      proven advocate for patient care and preserving incentives      for innovation, said Sam Taylor, President of the North      Carolina Biosciences Organization. On behalf of all North      Carolina life sciences companies, we salute Senator Hagan's      efforts.She is a true friend to our bioscience      community and the patients that we serve.\"    <\/p>\n<p>      More than 200 biotechnology industry representatives from 41      states will participate in hundreds of meetings with Members      of the House and Senate during the BIO Legislative Day      Fly-In.Participants will discuss issues critical to the      biotechnology industry including reauthorization of the      Prescription Drug User Fee Act, the Transforming the      Regulatory Environment to Accelerate Access to Treatments      (TREAT) Act\/Faster Access to Specialized Treatments (FAST)      Act, adequate reimbursement for vital therapies under      Medicare, and capital formation issues relevant to      biotechnology companies.    <\/p>\n<p>      Photos of the award presentation are available upon      request.    <\/p>\n<p>      BIO represents more than 1,100 biotechnology companies,      academic institutions, state biotechnology centers and      related organizations across the United States and in more      than 30 other nations. BIO members are involved in the      research and development of innovative healthcare,      agricultural, industrial and environmental biotechnology      products. BIO also produces the BIO International Convention,      the worlds largest gathering of the biotechnology industry,      along with industry-leading investor and partnering meetings      held around the world.    <\/p>\n<\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/senator-hagan-honored-bio-legislator-080000658.html;_ylt=A2KJjb0HA5lPHDQAPwT_wgt.\" title=\"Senator Hagan Honored as BIO Legislator of the Year\" rel=\"noopener\">Senator Hagan Honored as BIO Legislator of the Year<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay Hagan (D-NC) as Legislator of the Year for 2011-2012. Senator Hagan receives the award in conjunction with todays BIO Legislative Day Fly-In reception <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/senator-hagan-honored-as-bio-legislator-of-the-year.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036318","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036318"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036318"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036318\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}